The global eosinophilic esophagitis drug market size is expected to reach US$ 189.7 million by 2028 according to a new study by Polaris Market Research. The report “Eosinophilic Esophagitis Drug Market Share, Size, Trends, Industry Analysis Report, By Product (Off-Label Drugs, Budesonide Oral Suspension, Fluticasone ODT, Mepolizumab, Reslizumab, Benralizumab, Dupilunab, Omalizumab, QAX576, AKOO2, and Losartan); By Diagnosis; By Treatment; By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market for eosinophilic esophagitis drug is driven by the growing prevalence of type II inflammatory disorders including EoE, advances in the treatment procedures, and intense competition among players for the first FDA approved drug to have a first-mover advantage. Huge unmet in EoE is also favoring the growth of the eosinophilic esophagitis drug industry. Diagnosis criteria of EoE are imperfect, as it is derived by expert opinions (with consensus between gastroenterologists, allergists, and pathologists), rather than being evidence-based. Currently, histologic criteria for EoE is not clear and it requires repeated tissue assessment to confirm disease onset, as there is no coherence between disease activity with patient symptoms.
The global eosinophilic esophagitis drug industry is fragmented based on the product, diagnosis, treatment, and region. In terms of product, the market is segmented into off-label drugs, Budesonide Oral Suspension, fluticasone ODT, Mepolizumab, Reslizumab, Benralizumab, Dupilunab, Omalizumab, QAX576, AKOO2, and losartan. Based on the diagnosis, the market for eosinophilic esophagitis is further bifurcated into upper endoscopy, esophagus biopsy, blood tests, others. Based on treatment, the eosinophilic esophagitis market is further bifurcated into dietary therapy, medication, dilation, others.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/eosinophilic-esophagitis-drug-market/request-for-sample
Polaris Market Research has segmented the eosinophilic esophagitis drug market report on the basis of product, diagnosis, treatment, and region:
Eosinophilic Esophagitis Drug, Product Outlook (Revenue - USD Million, 2016 - 2028)
Eosinophilic Esophagitis Drug, Diagnosis Outlook (Revenue - USD Million, 2016 - 2028)
Eosinophilic Esophagitis Drug, Treatment Outlook (Revenue - USD Million, 2016 - 2028)
Eosinophilic Esophagitis Drug, Regional Outlook (Revenue - USD Million, 2016 - 2028)